Engineered Ancestral Enzyme Converts ADP Into ATP
The variant achieves a 7,500-fold higher turnover rate than p-loop prototypes, advancing the design of synthetic catalysts.
Updated on Oct. 29, 2026 in Life Sciences
Live Poll
Should the federal government prioritize funding for research into the origins of early life?
On October 9, 2026, researchers published findings on a synthetic, ancestral protein variant capable of converting ADP into ATP and AMP. This research-stage study demonstrates that an enzyme built with a restricted set of amino acids can successfully execute a critical biological phosphorylation reaction.
Why it matters
Understanding how primitive enzymes functioned with minimal amino acid repertoires provides insight into the chemical origins of life. This work also establishes a new design framework for creating artificial enzymes with simplified building blocks.
The Arc1-12KR variant, which lacks catalytic histidine, demonstrates an ATP-forming turnover rate of 1.5 s⁻¹ vs. a benchmark 7,500 times slower for standard p-loop prototypes. X-ray crystallography and molecular dynamics confirmed that the enzyme utilizes aspartate and arginine residues alongside magnesium ions to complete the reaction.
The details
Researchers engineered the Arc1-12KR variant to test if an enzyme could maintain functionality with a restricted amino acid repertoire, reflecting conditions of early life. The protein facilitates phosphoryl-transfer—a process where a phosphate group is moved between molecules—by relying on aspartate and arginine residues in the presence of magnesium ions rather than the typical histidine-based mechanism. High-performance liquid chromatography and mass spectrometry confirmed the successful conversion of two ADP molecules into one ATP molecule and one AMP molecule.
Timeline
October 9, 2026: The study was published in Angewandte Chemie International Edition.
The Tech Race
This development follows the pattern set by the RNA world hypothesis by investigating how early life-sustaining functions emerged through simple chemical systems. The findings extend this investigation by showing that functional metabolic reactions do not strictly require modern, complex protein architectures.
This research provides a new toolkit for synthetic biology, potentially informing the design of industrial enzymes that use fewer, cheaper, or more sustainable amino acid building blocks. While currently in the research phase, this approach offers a framework for future biocatalyst development.
The takeaway
This study demonstrates that primitive, restricted-repertoire enzymes can achieve high-performance metabolic turnover, challenging assumptions about the complexity required for early life. Future research will likely focus on whether these minimal designs can scale to more complex, multi-step enzymatic pathways.
Further reading
For more research on how biological systems evolve at the molecular level, visit the Life Sciences section.
More information
Read the full study in the scientific journal research publication.
Source note: This article includes information reported by News-Medical.
Live Poll
Should the federal government prioritize funding for research into the origins of early life?
